Glucosamine and O-GlcNAcylation: a novel immunometabolic therapeutic target for OA and chronic, low-grade systemic inflammation?

Ann Rheum Dis. 2020 Oct;79(10):1261-1263. doi: 10.1136/annrheumdis-2020-217454. Epub 2020 Jun 18.
No abstract available

Keywords: cardiovascular diseases; inflammation; osteoarthritis; therapeutics.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylation
  • Animals
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / immunology
  • Cardiovascular Diseases / metabolism
  • Glucosamine / pharmacology*
  • Humans
  • Inflammation* / complications
  • Inflammation* / immunology
  • Inflammation* / metabolism
  • Osteoarthritis* / complications
  • Osteoarthritis* / immunology
  • Osteoarthritis* / metabolism

Substances

  • Glucosamine